NSGCX
Price
$20.66
Change
+$0.11 (+0.54%)
Updated
Oct 8 closing price
Net Assets
1.7B
VITSX
Price
$161.52
Change
+$1.03 (+0.64%)
Updated
Oct 8 closing price
Net Assets
2.02T
Interact to see
Advertisement

NSGCX vs VITSX

Header iconNSGCX vs VITSX Comparison
Open Charts NSGCX vs VITSXBanner chart's image
Columbia Cornerstone Equity C
Price$20.66
Change+$0.11 (+0.54%)
VolumeN/A
Net Assets1.7B
Vanguard Total Stock Market Idx I
Price$161.52
Change+$1.03 (+0.64%)
VolumeN/A
Net Assets2.02T
NSGCX vs VITSX Comparison Chart in %
View a ticker or compare two or three
VS
NSGCX vs. VITSX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NSGCX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 2.02T vs. NSGCX (1.7B). VITSX pays higher dividends than NSGCX: VITSX (1.14) vs NSGCX (0.00). NSGCX was incepted earlier than VITSX: NSGCX (26 years) vs VITSX (28 years). NSGCX (1.85) is less costly to investors than VITSX (0.03). NSGCX is a more actively managed with annual turnover of: 56.00 vs. VITSX (2.00). NSGCX has a lower initial minimum investment than VITSX: NSGCX (2000) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 16.78 vs. NSGCX (7.31). VITSX return over 5 years is better than : 86.62 vs. NSGCX (40.59).
NSGCXVITSXNSGCX / VITSX
Total Expense Ratio1.650.035,500%
Annual Report Gross Expense Ratio1.850.036,167%
Fund Existence26 years28 years-
Gain YTD7.36713.85953%
Front LoadN/AN/A-
Min. Initial Investment200050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.7B2.02T0%
Annual Yield % from dividends0.001.14-
Returns for 1 year7.3116.7844%
Returns for 3 years57.9081.2671%
Returns for 5 years40.5986.6247%
Returns for 10 years96.50230.2042%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XBOTF0.380.02
+5.33%
REALBOTIX CORP
KKPCF28.09N/A
N/A
Kaken Pharmaceutical Co., Ltd.
RWCRF0.38N/A
N/A
RIWI Corp.
BRDCF46.72N/A
N/A
Bridgestone Corp.
SLFPF2.73N/A
N/A
ABERDEEN GROUP PLC